<DOC>
	<DOCNO>NCT01103284</DOCNO>
	<brief_summary>This study look treatment effect DiaPep277 preservation beta-cell function , define meal-stimulated secretion insulin . DiaPep277 peptide change way immune system behaves , stop attack beta-cells . Adults ( &gt; 20 year ) newly diagnose ( &lt; 6 month ) type 1 diabetes treat 10 injection DiaPep277 Placebo 2-year treatment follow-up period .</brief_summary>
	<brief_title>Efficacy Safety Study DiaPep277 Newly Diagnosed Type 1 Diabetes Adults</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>clinical diagnosis type 1 diabetes within last 6 month Age 2045 year fast basal Cpeptide equal great 0.22 nmol/L , low 0.8 nmol/L BMI 17 30 screening Significant disease condition type 1 diabetes Diabetesrelated complication Ongoing treatment immunosuppressive immunomodulating agent include chronic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>beta-cells</keyword>
	<keyword>autoimmune</keyword>
	<keyword>Diabetes</keyword>
	<keyword>immunomodulation</keyword>
</DOC>